Alfredo A Paredes

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “5 Anticholinergic Medications, Cognition, and Parkinson’s Disease. Do Medications matter?”.

5 Anticholinergic Medications, Cognition, and Parkinson’s Disease. Do Medications matter?

Journal of the International Neuropsychological Society(2023)10.1017/s1355617723002035

N/A

0DataRank · unranked

1 citations

Lauren Kenney, Alyssa Ray, Alfredo A Paredes, Adrianna Ratajska, Dawn Bowers +1 more

Anticholinergic Medication Burden and Cognitive Subtypes in Parkinson’s Disease without Dementia

Archives of Clinical Neuropsychology(2024)10.1093/arclin/acae041

N/A

0DataRank · unranked

1 citations

Lauren Kenney, Alyssa Ray, Alfredo A Paredes, Adrianna Ratajska, Kara Eversole +5 more

Glucagon-like Peptide-1 Receptor Agonist Use and Risk of Cataract Development

American Journal of Ophthalmology(2025)10.1016/j.ajo.2025.10.021

N/A

0DataRank · unranked

5 citations

Alfredo A Paredes, SEJAL A. AHUJA, Benjamin K. Young, Abhimanyu S. Ahuja

Reply to Comment on Glucagon-Like Peptide-1 Receptor Agonist Use and Risk of Cataract Development

American Journal of Ophthalmology(2025)10.1016/j.ajo.2025.12.021

N/A

0DataRank · unranked

0 citations

Alfredo A Paredes, Sejal Ahuja, Benjamin K. Young, Abhimanyu S. Ahuja